Page last updated: 2024-11-04

terbutaline and Autoimmune Diseases

terbutaline has been researched along with Autoimmune Diseases in 2 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Carvajal Gonczi, CM1
Hajiaghayi, M1
Gholizadeh, F1
Xavier Soares, MA1
Touma, F1
Lopez Naranjo, C1
Rios, AJ1
Pozzebon, C1
Daigneault, T1
Burchell-Reyes, K1
Darlington, PJ1
Wahle, M1
Pierer, M1
Krause, A1
Kolker, S1
Baerwald, CG1

Other Studies

2 other studies available for terbutaline and Autoimmune Diseases

ArticleYear
The β2-adrenergic receptor agonist terbutaline upregulates T helper-17 cells in a protein kinase A-dependent manner.
    Human immunology, 2023, Volume: 84, Issue:10

    Topics: Adrenergic Agonists; Asthma; Autoimmune Diseases; CD28 Antigens; Cyclic AMP-Dependent Protein Kinase

2023
Decreased catecholamine-induced cell death in B lymphocytes from patients with rheumatoid arthritis.
    Annals of the New York Academy of Sciences, 2002, Volume: 966

    Topics: Adrenergic beta-Agonists; Annexin A5; Antibodies, Anti-Idiotypic; Apoptosis; Arthritis, Rheumatoid;

2002